PERSONALIS

personalis-logo

Personalis combines both the technology of sequencing and interpretation, with an extensive history of peer-reviewed publication and commercial success. It is providing an extensive molecular view of a patient’s tumor and characterizes its interplay with the immune system. It aids in the development of safer, effective precision cancer therapies, immunotherapies, and personalized medicines.

#SimilarOrganizations #People #Financial #Event #Website #More

PERSONALIS

Industry:
Biotechnology Genetics Health Care Health Diagnostics

Founded:
2011-08-01

Address:
Menlo Park, California, United States

Country:
United States

Website Url:
http://www.personalis.com

Total Employee:
251+

Status:
Active

Contact:
+1 650 752 1301

Email Addresses:
[email protected]

Total Funding:
225.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

bluebird-bio-logo

Bluebird Bio

Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.

cofactor-genomics-logo

Cofactor Genomics

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

neogenomics-logo

NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

caredx-logo

CareDx

CareDx is a novel mol­e­c­u­lar diagnos­tics com­pany.


Current Advisors List

woodrow-myers_image

Woodrow Myers Member Board Of Directors @ Personalis
Board_member
2021-03-01

Current Employees Featured

john-west_image

John West
John West Chief Executive Officer @ Personalis
Chief Executive Officer
2011-08-01

aaron-tachibana_image

Aaron Tachibana
Aaron Tachibana Chief Financial Officer @ Personalis
Chief Financial Officer
2019-03-01

clinton-musil_image

Clinton Musil
Clinton Musil Chief Business Officer @ Personalis
Chief Business Officer

carol-j-tillis_image

Carol J. Tillis
Carol J. Tillis Vice President, Finance & Administration @ Personalis
Vice President, Finance & Administration
2011-01-01

christian-haudenschild_image

Christian Haudenschild
Christian Haudenschild Senior Vice President @ Personalis
Senior Vice President
2021-08-01

dawn-mchugh_image

Dawn McHugh
Dawn McHugh Senior Director, Strategic Business Development @ Personalis
Senior Director, Strategic Business Development
2020-04-01

laurie-goodman_image

Laurie Goodman
Laurie Goodman Senior Director, Scientific & Medical Affairs @ Personalis
Senior Director, Scientific & Medical Affairs
2021-04-01

stanley-welle_image

Stanley Welle
Stanley Welle Director, Strategic Business Development @ Personalis
Director, Strategic Business Development
2020-01-01

not_available_image

James Azzaro
James Azzaro Vice President of Diagnostic Sales @ Personalis
Vice President of Diagnostic Sales
2022-04-01

richard-chen_image

Richard Chen
Richard Chen Chief Medical Officer and SVP of R&D @ Personalis
Chief Medical Officer and SVP of R&D

Founder


atul-butte_image

Atul Butte

Stock Details


Company's stock symbol is NASDAQ:PSNL

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Series C - Personalis

stanford-university_image

Stanford University

Stanford University investment in Series C - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series C - Personalis

mohr-davidow-ventures_image

Mohr Davidow Ventures

Mohr Davidow Ventures investment in Series C - Personalis

abingworth-management_image

Abingworth

Abingworth investment in Series B - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series B - Personalis

mohr-davidow-ventures_image

Mohr Davidow Ventures

Mohr Davidow Ventures investment in Series B - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series A - Personalis

abingworth-management_image

Abingworth

Abingworth investment in Series A - Personalis

stanford-university_image

Stanford University

Stanford University investment in Series A - Personalis

Newest Events participated

ici-boston-2017_event_image Participated in ICI Boston 2017 on 2017-03-14 as exhibitor

Official Site Inspections

http://www.personalis.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.85 K

  • Host name: 172.67.73.134
  • IP address: 172.67.73.134
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Personalis"

Contact - Personalis

Headquarters (Office and Laboratory) Personalis, Inc. 6600 Dumbarton Circle Fremont, CA 94555 USA Directions and Map (Google Maps) Hours of Operation: Monday – Friday 9 AM – 5See details»

Personalis | Personalizing Precision Oncology | Since 2011

Personalis was founded in 2011 by a team of internationally-renowned next-generation sequencing (NGS) thought-leaders from Stanford University. We’re committed to building a world where personalized testing provides greater …See details»

Personalis - Crunchbase Company Profile & Funding

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine. Personalis reported a reduction in its loss per share from US$0.61 in Q1 2023 to US$0.26 in Q1 2024.See details»

Personalis, Inc. - LinkedIn

Personalis, Inc. | 23,084 followers on LinkedIn. Personalizing Precision Oncology | At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We ...See details»

Personalis - Contacts, Employees, Board Members, Advisors

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine. Search Crunchbase. Start Free Trial . Chrome …See details»

Personalis Company Profile - Office Locations, Competitors, …

Oct 29, 2024 Personalis has 5 employees across 2 locations and $73.48 m in annual revenue in FY 2023. See insights on Personalis including office locations, competitors, revenue, …See details»

Personalis CEO and Key Executive Team | Craft.co

Personalis's Interim CEO and Chief Financial Officer is Aaron Tachibana. Other executives include Christopher Hall, President; Richard Chen, Senior Vice President R&D and Chief …See details»

Personalis Named to Inc.'s 2021 Best-Led Companies List | Personalis

Nov 12, 2021 Personalis recognized in inaugural roundup for proven track record of management excellence. MENLO PARK, Calif.--(BUSINESS WIRE)--Nov. 12, 2021- …See details»

Personalis Reports Third Quarter 2022 Financial Results | Personalis

Sep 30, 2022 MENLO PARK, Calif.--(BUSINESS WIRE)--Nov. 2, 2022--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported …See details»

Personalis Expands Leadership Team with Appointment of Susan …

Feb 8, 2021 “Susan Moriconi brings over 20 years of experience in human resources and organization strategy, including deep experience in the life sciences industry. She is the right …See details»

Personalis | Meet the Team | Active cancer management

Meet the people building the next standard of cancer care. Everyone has the power to impact our pursuit of personalized, active cancer management.See details»

What is Personalis? Company Culture, Mission, Values

How do job seekers rate their interview experience at Personalis? 46% of job seekers rate their interview experience at Personalis as positive. Candidates give an average difficulty score of …See details»

Personalis (PSNL) Earnings Date and Reports 2025 - MarketBeat

Nov 29, 2024 Personalis announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.64, which missed the consensus estimate of -$0.33 by $0.31. Quarterly revenue was …See details»

Personalis Further Expands Leadership Team With Appointment of …

Jul 16, 2020 MENLO PARK, Calif.--(BUSINESS WIRE)--Jul. 16, 2020--Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the appointment …See details»

What Is a Personal Organization Strategy? (With Steps)

Jun 28, 2024 The organization system also combines various features to help you feel more relaxed, save time, and improve energy levels. These features can include prioritization …See details»

Careers in Precision Oncology - Personalis

Jan 26, 2022 We’re looking for team members who are driven to advance the field of precision oncology. Together, we can transform the future of cancer care.See details»

How To Develop and Implement a Personal Organization System

Aug 15, 2024 A personal organization system is a process you can follow to effectively sort, order and manage your tasks. This allows you to follow a clear routine each day to ensure you …See details»

Personalis | Recent Announcements | Stay in the know

Jun 26, 2024 From headlines and conference appearances to research papers, webinars and blog posts, if it’s about Personalis, you’ll find it here.See details»

Personalis | News

Read the latest press about Personalis. Learn what we’ve accomplished, see who we’re collaborating with, and find out where we’re going next.See details»

linkstock.net © 2022. All rights reserved